The Hidden Risk of Improvising Your CBD Dose
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "The Hidden Risk of Improvising Your CBD Dose", "articleBody": "Most people…
Recreational Cannabis and Medical Care Have Different Goals
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "Recreational Cannabis and Medical Care Have Different Goals", "articleBody":…
Can CBD Gummies Cause Psychosis? – Clinical Insights
CBD gummies psychosis clinical insights highlight the importance of patient screening and product quality. Emerging case reports raise questions about CBD's safety in vulnerable individuals. Clinicians must consider these insights when recommending…
CBD Gummies and Increased Libidos: What the Evidence Actually Shows
CBD gummies and libido enhancement are topics of growing interest in sexual health research. Current evidence on CBD gummies and libido enhancement remains limited and requires further clinical studies. Patients should approach CBD gummies and libido…
“Dosing by Guesswork: Why Evidence-Based Titration Matters”
Dr. Caplan’s Clinical Pearl When patients guess their dose without a clear understanding of their endocannabinoid system's unique needs, they're essentially playing medical roulette. The consequences can be unpredictable and sometimes…
Medical Cannabis for Autoimmune Pain Management According to Dr. Caplan
Patients with autoimmune conditions are increasingly turning to medical cannabis for autoimmune pain when traditional therapies prove insufficient. Dr. Caplan's clinical experience shows cannabis can provide meaningful adjunctive relief, though evidence…
Cannabinoid formulation patent describes improved controlled-release profile #6
A patent filing describes a controlled-release cannabinoid composition with potential therapeutic applications.
Cannabinoids in Mental Health Treatment: Efficacy and Safety Evidence
Clinical evidence for cannabinoids mental health treatment evidence remains limited and inconclusive. Current research does not establish clear efficacy or safety for mental disorders or substance use disorders. Patients and clinicians should approach…
Cancer Survivors Report Little Cannabis Stigma but Opioid Stigma Influences Pain Choices
This study highlights cannabis opioid stigma cancer survivors experience, influencing their pain management choices. Most survivors report little direct cannabis stigma but significant opioid stigma. This dynamic affects symptom management and…
Cannabinoid Clinical Trials: Mental Health Evidence
Clinical Takeaway Clinical Takeaway: Current randomized controlled trial evidence does not demonstrate established efficacy or safety of cannabinoids as primary treatment for mental disorders or substance use disorders. Existing research gaps mean…
